These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38484417)

  • 1. Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study.
    Stopka TJ; Estadt AT; Leichtling G; Schleicher JC; Mixson LS; Bresett J; Romo E; Dowd P; Walters SM; Young AM; Zule W; Friedmann PD; Go VF; Baker R; Fredericksen RJ
    Soc Sci Med; 2024 Apr; 346():116660. PubMed ID: 38484417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to retention in inpatient and residential drug treatment among persons who use opioids and/or injection drugs living in the rural U.S.
    Fredericksen RJ; Mixson LS; Estadt AT; Leichtling G; Bresett J; Zule W; Walters SM; Friedmann PD; Romo E; Whitney BM; Delaney JAC; Crane HM; Tsui JI; Young A; Seal D; Stopka TJ
    J Subst Use Addict Treat; 2024 Oct; 165():209453. PubMed ID: 39033853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach.
    Bunting AM; Oser CB; Staton M; Eddens KS; Knudsen H
    Addict Sci Clin Pract; 2018 Dec; 13(1):23. PubMed ID: 30509314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Incarceration, Substance Use, Overdose, and Service Use Among People Who Use Drugs in Rural Communities.
    Hoover DB; Korthuis PT; Waddell EN; Foot C; Conway C; Crane HM; Friedmann PD; Go VF; Nance RM; Pho MT; Satcher MF; Sibley A; Westergaard RP; Young AM; Cook R
    JAMA Netw Open; 2023 Nov; 6(11):e2342222. PubMed ID: 37943559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance use and opioid-related stigma among Black communities in the rural South.
    Cody SL; Newman S; Bui C; Sharp-Marbury R; Scott L
    Arch Psychiatr Nurs; 2023 Oct; 46():127-132. PubMed ID: 37813495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medications for opioid use disorder in rural primary care practices: Patient and provider experiences.
    Bridges NC; Taber R; Foulds AL; Bear TM; Cloutier RM; McDonough BL; Gordon AJ; Cochran GT; Donohue JM; Adair D; DiDomenico E; Pringle JL; Gellad WF; Kelley D; Cole ES
    J Subst Use Addict Treat; 2023 Nov; 154():209133. PubMed ID: 37543217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance Use Disorder Treatment, Perceived Need for Treatment, and Barriers to Treatment Among Parenting Women With Substance Use Disorder in US Rural Counties.
    Ali MM; Nye E; West K
    J Rural Health; 2022 Jan; 38(1):70-76. PubMed ID: 32613709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States.
    Lister JJ; Weaver A; Ellis JD; Himle JA; Ledgerwood DM
    Am J Drug Alcohol Abuse; 2020 May; 46(3):273-288. PubMed ID: 31809217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
    Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
    Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study.
    Poulsen MN; Asdell PB; Berrettini W; McBryan K; Rahm AK
    SSM Ment Health; 2022 Dec; 2():. PubMed ID: 36776723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of medication for opioid use disorder treatment in Indian health clinics in California: A qualitative evaluation.
    Soto C; Miller K; Moerner L; Nguyen V; Ramos GG
    J Subst Use Addict Treat; 2023 Dec; 155():209115. PubMed ID: 37399928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study.
    David AR; Sian CR; Gebel CM; Linas BP; Samet JH; Sprague Martinez LS; Muroff J; Bernstein JA; Assoumou SA
    J Subst Abuse Treat; 2022 Nov; 142():108870. PubMed ID: 36084559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators.
    O'Grady MA; Elkington KS; Robson G; Achebe IY; Williams AR; Cohall AT; Cohall R; Christofferson M; Garcia A; Ramsey KS; Lincourt P; Tross S
    Subst Abuse Treat Prev Policy; 2024 Jan; 19(1):12. PubMed ID: 38287329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intersecting Substance Use Disorder and Unmet Social Needs in Rural Pregnant Women.
    Allen S; Dev A; Canavan C; Goodman D
    J Obstet Gynecol Neonatal Nurs; 2024 Sep; 53(5):485-490. PubMed ID: 38796173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites.
    Watson DP; Staton MD; Gastala N
    Addict Sci Clin Pract; 2022 Jul; 17(1):41. PubMed ID: 35902890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Indian and Alaska Native substance use treatment: Barriers and facilitators according to an implementation framework.
    Shukla R; Turner BJ; Ramos GG; Love M; D'Isabella J; Soto C
    J Subst Use Addict Treat; 2023 Dec; 155():209095. PubMed ID: 37277023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "In their mind, they always felt less than": The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention.
    Anvari MS; Kleinman MB; Massey EC; Bradley VD; Felton JW; Belcher AM; Magidson JF
    J Subst Abuse Treat; 2022 Jul; 138():108721. PubMed ID: 35067397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
    Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "I would do anything but that": Attitudes towards sex work among rural people who use drugs.
    Rains A; Sibley AL; Levander XA; Walters SM; Nolte K; Colston DC; Piscalko HM; Go VF; Friedmann PD; Seal DW
    Int J Drug Policy; 2023 Dec; 122():104237. PubMed ID: 37865053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.